These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24780471)

  • 1. Clinical studies and chronic kidney disease: what did we learn recently?
    Liabeuf S; Neirynck N; Drüeke TB; Vanholder R; Massy ZA
    Semin Nephrol; 2014 Mar; 34(2):164-79. PubMed ID: 24780471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future Avenues to Decrease Uremic Toxin Concentration.
    Vanholder RC; Eloot S; Glorieux GL
    Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal removal of uremic toxins: can we still do better?
    Eloot S; Ledebo I; Ward RA
    Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Middle-Molecule Uremic Toxins and Outcomes in Chronic Kidney Disease.
    Massy ZA; Liabeuf S
    Contrib Nephrol; 2017; 191():8-17. PubMed ID: 28910787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and clinical implications of protein-bound uremic toxins.
    Jansen J; Jankowski J; Gajjala PR; Wetzels JFM; Masereeuw R
    Clin Sci (Lond); 2017 Jul; 131(14):1631-1647. PubMed ID: 28667064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical Appraisal of Limitations in the Current Definition/Classification of Uremic Toxins.
    Husain-Syed F; Vanholder R; Rosner MH; Kawanishi H; Sirich TL; Ronco C
    Blood Purif; 2023; 52(3):221-232. PubMed ID: 36513030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondialyzable uremic toxins.
    Piroddi M; Bartolini D; Ciffolilli S; Galli F
    Blood Purif; 2013; 35 Suppl 2():30-41. PubMed ID: 23676834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins.
    Ciceri P; Cozzolino M
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The kidney and uremic toxin removal: glomerulus or tubule?
    Masereeuw R; Mutsaers HA; Toyohara T; Abe T; Jhawar S; Sweet DH; Lowenstein J
    Semin Nephrol; 2014 Mar; 34(2):191-208. PubMed ID: 24780473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and clinical evidence for uremic toxicity.
    Bouré T; Vanholder R
    Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of protein-bound toxins, possibility for blood purification therapy.
    Neirynck N; Glorieux G; Schepers E; Pletinck A; Dhondt A; Vanholder R
    Blood Purif; 2013; 35 Suppl 1():45-50. PubMed ID: 23466378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis.
    Reis T; Hutchison C; de Assis Rocha Neves F; Zawadzki B; Zanella M; Ronco C; Rosner MH
    Blood Purif; 2023; 52(3):242-254. PubMed ID: 36657410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Uremic toxins: the case of protein-bound compounds].
    Basile C; Libutti P; Teutonico A; Lomonte C
    G Ital Nefrol; 2010; 27(5):498-507. PubMed ID: 20922681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uremic Toxins and Blood Purification: A Review of Current Evidence and Future Perspectives.
    Magnani S; Atti M
    Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33808345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U; Vienken J; Ward RA
    Semin Dial; 2009; 22(4):454-7. PubMed ID: 19709001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous variability of pre-dialysis concentrations of uremic toxins over time in stable hemodialysis patients.
    Eloot S; Van Biesen W; Roels S; Delrue W; Schepers E; Dhondt A; Vanholder R; Glorieux G
    PLoS One; 2017; 12(10):e0186010. PubMed ID: 29016645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy.
    Vanholder R; Boelaert J; Glorieux G; Eloot S
    Semin Dial; 2015; 28(2):114-24. PubMed ID: 25441338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.